MAL2 and hepatocellular carcinoma: The approach was straightforward and in three parts: (1) overexpress MAL2 in WIF-B cells; (2) knock down MAL2 in Hep3B HCC cells; and (3) express MAL2 in Clone 9 hepatoma cells.